GLPwatch
Papers (10389)
Page 170 of 174, ranked by citation count.
- Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis.
- [GLP-1 receptor agonists in hypertension - a new approach for difficult-to-treat blood pressure?]
- Effect of ketogenic diet plus dulaglutide on glucose and lipid metabolism in diabetes mellitus.
- Efficacy of Tirzepatide, Retatrutide, and Semaglutide for Weight Loss in Obese Individuals Without Diabetes.
- Systemic Pharmacokinetic Principles of Therapeutic Peptides.
- Mo-Rubbing abdominal improves metabolic homeostasis in type 2 diabetes mellitus mice via a jejunum-specific GLP1-dependent mechanism.
- Comparing the performance of electrostatic repulsion-reversed phase chromatography approaches in the resolution of complex peptide mixture: Liraglutide as case study.
- Drugs and devices for weight management.
- Benchmarking the medication efficiency and technological progress of diabetes drugs.
- Calories to satiation-A new predictor of anti-obesity therapy outcome?
- Exploring the cardiopulmonary effects of tirzepatide in atrial fibrillation and comorbid chronic obstructive pulmonary disease.
- Weight trajectories after last tirzepatide or semaglutide prescription across a federated health network.
- Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum - Mechanisms, evidence, and future directions.
- Glucagon-like Peptide-1 Receptor Agonists and Alcohol Use Outcomes: A Systematic Review of Clinical Evidence.
- Response to "Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes".
- Web Exclusive. Annals On Call - Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control Is Inadequate With Dulaglutide.
- Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.
- Hepatic portal venous gas in a patient with diabetes on GLP-1 receptor agonist and alpha-glucosidase inhibitor.
- Exploring the Potential Link Between Tirzepatide and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): Evidence from FAERS and Google Trends.
- Factors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussions.
- Corrigendum to Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
- A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
- [Glucagon-like peptide 1 agonists : the fourth pillar of nephroprotection in type 2 diabetes].
- [Technological Innovations in Diabetes Therapy].
- COMBINE 2 is better than one: shaping the future of therapeutics in inadequately controlled type 2 diabetes.
- Real-World Effectiveness and Safety of Tirzepatide, Semaglutide, and Liraglutide in Adults with Overweight or Obesity without Diabetes: A Comparative Study.
- [Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBYII study (observations lasting 24 months)].
- A cardiovascular indication for oral semaglutide (Rybelsus).
- Tirzepatide for Obstructive Sleep Apnea: A Novel Therapeutic Promise and the Perioperative Considerations.
- Semaglutide use in a patient with a long-term ileostomy: A case report highlighting clinical risks and evidence gaps.
- Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs).
- Musculoskeletal adverse events with incretin-based diabetes drugs: a FAERS pharmacovigilance study.
- Obesity medications and acquired hypothalamic obesity in adults: A two-case experience.
- Distinguishing among incretin-based therapies. Patient education and self-management.
- Can early use of insulin, GLP-1 halt diabetes progression?
- Obesity and heart failure-the role of GLP-1 receptor agonists.
- Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK.
- A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance.
- Tirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function improvement.
- In brief: Removal of suicidality warning from GLP-1 Agonists for weight management.
- Oral semaglutide (Wegovy) for weight loss.
- Antihyperglycemic medications for cardiovascular disease risk reduction.
- Semaglutide (Wegovy) for MASH.
- Efficacy of GLP-1 receptor agonists in Parkinson's disease: a systematic review and exploratory network meta-analysis of randomized controlled trials.
- [A case of an elderly diabetic patient with dementia effectively treated with weekly exenatide].
- Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice.
- Weight Loss With GLP-1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta-Analysis.
- Comparison table: Some drugs for weight management.
- Toward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical Practice.
- The effect of exenatide (GLP-1a) and sitagliptin (DPP-4i) on paraoxonase 1 (PON1) activity and expression in normal and fructose-fed rats.
- [Effectiveness of GLP-1 receptor agonists in managing patients with type 2 diabetes].
- Exendin-4 enhances insulin-positive phenotype of human pluripotent stem cell-derived β cells during transplantation.
- GLP-1 Receptor Agonist Use and Wound Outcomes After Free Flap Breast Reconstruction.
- Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.
- Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.
- Efficacy of Simplifying Complex Insulin Regimen on Glycometabolic Parameters and Target Organ Damage in Type 2 Diabetes: A Retrospective Cohort Study.
- Cutaneous Allodynia Associated With GLP-1RA Tirzepatide for Weight Management: A Case Series.
- Modelling G protein-biased agonism using GLP-1 receptor C-terminal mutations.
- Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF.
- [Conserved W52 led to reduced binding of glucogan-like peptide 1 receptor].